approval
saveSANDIMMUNE (CYCLOSPORINE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 214d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 214d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 6, 2026 · 214d ago
- approvalCYCLOSPORINE — FDA approvalNov 28, 2025 · 312d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1104d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023 · 1104d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 16, 2022 · 1665d ago
- approvalSANDIMMUNE (CYCLOSPORINE) — FDA approvalJul 14, 2016 · 3736d ago
same company · ±60 days · 6
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalSep 28, 2023
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalOct 6, 2023
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalOct 6, 2023
- approvalcarbamazepine ER: TEGRETOL-XR (CARBAMAZEPINE) — FDA approvalSep 13, 2023
- approvalcarbamazepine ER: TEGRETOL (CARBAMAZEPINE) — FDA approvalSep 13, 2023
comments(0)
5-min edit window · permanent after that